Gennex Lab.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE509C01026
NSEID:
BSEID: 531739
View on BSE

INR

10.04

-0.3 (-2.9%)

BSENSE

Jun 11, 03:30 PM

BSE+NSE Vol: 2.73 lacs

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Ambalal Sarabhai

BDH Industries

Aarey Drugs

Trident Lifeline

Gennex Lab.

Zenotech Lab.

Everest Organics

Lyka Labs

Astonea Labs

Sat Kartar Life

Infinium Pharma

Why is Gennex Laboratories Ltd ?

Underperformed the market in the last 1 year

Even though the market (BSE500) generated negative returns of -5.53% in the last 1 year, its fall in the stock was much higher with a return of -23.48%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Gennex Lab. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Gennex Lab.

-23.48%

-0.42

55.25%

Sensex

-10.52%

-0.81

13.06%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

24.21%

EBIT Growth (5y)

32.40%

EBIT to Interest (avg)

6.10

Debt to EBITDA (avg)

1.69

Net Debt to Equity (avg)

0.12

Sales to Capital Employed (avg)

0.80

Tax Ratio

9.72%

Dividend Payout Ratio

Pledged Shares

17.42%

Institutional Holding

0.00%

ROCE (avg)

12.32%

ROE (avg)

8.12%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.10

EV to EBIT

11.08

EV to EBITDA

9.99

EV to Capital Employed

1.09

EV to Sales

1.53

PEG Ratio

1.29

Dividend Yield

ROCE (Latest)

9.80%

ROE (Latest)

8.61%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company

PBT LESS OI(Q)

At Rs 3.65 cr has Grown at 1251.85%

PAT(Q)

At Rs 4.03 cr has Grown at 65.3%

NET SALES(Q)

Highest at Rs 60.96 cr

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...

Here's what is working for Gennex Lab.

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs 3.65 cr has Grown at 1251.85%

Year on Year (YoY)

MOJO Watch

Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Net Sales - Quarterly

At Rs 60.96 cr has Grown at 51.15%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs 4.03 cr has Grown at 65.3%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly

Highest at Rs 60.96 cr

in the last five quarters

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)